Literature DB >> 18403051

Physiological significance of high- and low-affinity agonist binding to neuronal and recombinant AMPA receptors.

Markus Kessler1, Erika Suzuki, Kyle Montgomery, Amy C Arai.   

Abstract

Radioligand binding studies have shown that AMPA receptors exist in two variants that differ about twenty-fold in their binding affinities, with brain receptors being mainly of the low-affinity type and recombinantly expressed receptors having almost exclusively high affinity. However, the physiological correlate of high- and low-affinity binding is not yet known. In this study we examined if physiological experiments similarly reveal evidence for two distinct receptor variants. We therefore measured equilibrium desensitization by glutamate and determined IC(50) values for neuronal receptors and for the homomeric receptors GluR1-4 expressed in HEK293 cells. Contrary to the prediction that these IC(50) values exhibit large differences commensurate with those of high- and low-affinity binding, values for homomeric receptors (1-18 microM) were on an average not different from those of neuronal receptors (3-10 microM). Moreover, simulations with kinetic receptor models suggest that the IC(50) values for neuronal and recombinant receptors correspond to the binding affinity of the low-affinity receptor variant. These findings indicate that the high-affinity binding measured in heterologous expression systems represents an immature receptor variant that does not contribute to the currents recorded from these cells, and that the functional low-affinity receptors are present in such small number that they are effectively masked in binding assays by the high-affinity receptors. Thus, in order to compare experimentally determined saturation binding profiles with those predicted by kinetic receptor models and with dose-response curves from physiological studies, it will be imperative to develop methods for isolating first the low-affinity receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18403051      PMCID: PMC2518457          DOI: 10.1016/j.neuint.2008.02.009

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  49 in total

1.  Interaction with the unfolded protein response reveals a role for stargazin in biosynthetic AMPA receptor transport.

Authors:  Wim Vandenberghe; Roger A Nicoll; David S Bredt
Journal:  J Neurosci       Date:  2005-02-02       Impact factor: 6.167

Review 2.  Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors.

Authors:  D Colquhoun
Journal:  Br J Pharmacol       Date:  1998-11       Impact factor: 8.739

3.  Stable expression of recombinant AMPA receptor subunits: binding affinities and effects of allosteric modulators.

Authors:  M Hennegriff; A Arai; M Kessler; P Vanderklish; M S Mutneja; G Rogers; R L Neve; G Lynch
Journal:  J Neurochem       Date:  1997-06       Impact factor: 5.372

4.  High- and low-affinity alpha-[3H]amino-3-hydroxy-5-methylisoxazole-4-propionic acid ([3H]AMPA) binding sites represent immature and mature forms of AMPA receptors and are composed of differentially glycosylated subunits.

Authors:  S Standley; G Tocco; N Wagle; M Baudry
Journal:  J Neurochem       Date:  1998-06       Impact factor: 5.372

5.  Use of [3H]fluorowillardiine to study properties of AMPA receptor allosteric modulators.

Authors:  Markus Kessler; Amy C Arai
Journal:  Brain Res       Date:  2005-10-26       Impact factor: 3.252

6.  Ultraviolet radiation, thiol reagents, and solubilization enhance AMPA receptor binding affinity via a common mechanism.

Authors:  R A Hall; A Quan; M Kessler; G Lynch
Journal:  Neurochem Res       Date:  1996-08       Impact factor: 3.996

7.  Surface expression of the AMPA receptor subunits GluR1, GluR2, and GluR4 in stably transfected baby hamster kidney cells.

Authors:  R A Hall; A Hansen; P H Andersen; T R Soderling
Journal:  J Neurochem       Date:  1997-02       Impact factor: 5.372

8.  Sialic acid residues indirectly modulate the binding properties of AMPA-type glutamate receptors.

Authors:  K B Hoffman; M Kessler; G Lynch
Journal:  Brain Res       Date:  1997-04-11       Impact factor: 3.252

9.  Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.

Authors:  Erika Suzuki; Markus Kessler; Kyle Montgomery; Amy C Arai
Journal:  Mol Pharmacol       Date:  2004-09-24       Impact factor: 4.436

10.  Pharmacological properties of homomeric and heteromeric GluR1o and GluR3o receptors.

Authors:  B S Nielsen; T G Banke; A Schousboe; D S Pickering
Journal:  Eur J Pharmacol       Date:  1998-11-06       Impact factor: 4.432

View more
  3 in total

1.  On the mechanisms of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor binding to glutamate and kainate.

Authors:  Michael K Fenwick; Robert E Oswald
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

2.  Modulation of agonist binding to AMPA receptors by 1-(1,4-benzodioxan-6-ylcarbonyl)piperidine (CX546): differential effects across brain regions and GluA1-4/transmembrane AMPA receptor regulatory protein combinations.

Authors:  Kyle E Montgomery; Markus Kessler; Amy C Arai
Journal:  J Pharmacol Exp Ther       Date:  2009-08-28       Impact factor: 4.030

3.  Vesicular release probability sets the strength of individual Schaffer collateral synapses.

Authors:  Céline D Dürst; J Simon Wiegert; Christian Schulze; Nordine Helassa; Katalin Török; Thomas G Oertner
Journal:  Nat Commun       Date:  2022-10-17       Impact factor: 17.694

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.